Logo image of PETQ

PETIQ INC (PETQ) Stock Fundamental Analysis

NASDAQ:PETQ - US71639T1060 - Common Stock

30.98 USD
-0.01 (-0.03%)
Last: 10/24/2024, 8:00:01 PM
30.98 USD
0 (0%)
After Hours: 10/24/2024, 8:00:01 PM
Fundamental Rating

5

Overall PETQ gets a fundamental rating of 5 out of 10. We evaluated PETQ against 104 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of PETQ get a neutral evaluation. Nothing too spectacular is happening here. PETQ has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year PETQ was profitable.
PETQ had a positive operating cash flow in the past year.
PETQ had negative earnings in 4 of the past 5 years.
PETQ had a positive operating cash flow in 4 of the past 5 years.
PETQ Yearly Net Income VS EBIT VS OCF VS FCFPETQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

With a decent Return On Assets value of 1.48%, PETQ is doing good in the industry, outperforming 61.74% of the companies in the same industry.
PETQ has a better Return On Equity (5.13%) than 67.83% of its industry peers.
The Return On Invested Capital of PETQ (7.96%) is better than 80.87% of its industry peers.
PETQ had an Average Return On Invested Capital over the past 3 years of 4.51%. This is significantly below the industry average of 9.61%.
The last Return On Invested Capital (7.96%) for PETQ is above the 3 year average (4.51%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.48%
ROE 5.13%
ROIC 7.96%
ROA(3y)-2.53%
ROA(5y)-4%
ROE(3y)-9.44%
ROE(5y)-13.98%
ROIC(3y)4.51%
ROIC(5y)N/A
PETQ Yearly ROA, ROE, ROICPETQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30

1.3 Margins

PETQ has a better Profit Margin (1.17%) than 64.35% of its industry peers.
PETQ has a Operating Margin of 6.32%. This is in the better half of the industry: PETQ outperforms 70.43% of its industry peers.
PETQ's Operating Margin has improved in the last couple of years.
PETQ has a Gross Margin of 24.63%. This is comparable to the rest of the industry: PETQ outperforms 52.17% of its industry peers.
In the last couple of years the Gross Margin of PETQ has grown nicely.
Industry RankSector Rank
OM 6.32%
PM (TTM) 1.17%
GM 24.63%
OM growth 3YN/A
OM growth 5Y28.63%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5Y7.79%
PETQ Yearly Profit, Operating, Gross MarginsPETQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PETQ is creating some value.
Compared to 1 year ago, PETQ has more shares outstanding
PETQ has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PETQ has been reduced compared to a year ago.
PETQ Yearly Shares OutstandingPETQ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
PETQ Yearly Total Debt VS Total AssetsPETQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

PETQ has an Altman-Z score of 2.60. This is not the best score and indicates that PETQ is in the grey zone with still only limited risk for bankruptcy at the moment.
PETQ has a Altman-Z score of 2.60. This is in the better half of the industry: PETQ outperforms 66.09% of its industry peers.
The Debt to FCF ratio of PETQ is 36.99, which is on the high side as it means it would take PETQ, 36.99 years of fcf income to pay off all of its debts.
PETQ has a Debt to FCF ratio of 36.99. This is comparable to the rest of the industry: PETQ outperforms 54.78% of its industry peers.
PETQ has a Debt/Equity ratio of 1.69. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.69, PETQ is doing worse than 73.04% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF 36.99
Altman-Z 2.6
ROIC/WACC1.05
WACC7.57%
PETQ Yearly LT Debt VS Equity VS FCFPETQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 2.58 indicates that PETQ has no problem at all paying its short term obligations.
PETQ has a better Current ratio (2.58) than 82.61% of its industry peers.
PETQ has a Quick Ratio of 1.68. This is a normal value and indicates that PETQ is financially healthy and should not expect problems in meeting its short term obligations.
PETQ has a better Quick ratio (1.68) than 66.09% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 1.68
PETQ Yearly Current Assets VS Current LiabilitesPETQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

6

3. Growth

3.1 Past

PETQ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.58%, which is quite impressive.
Measured over the past 5 years, PETQ shows a small growth in Earnings Per Share. The EPS has been growing by 7.07% on average per year.
The Revenue has grown by 13.57% in the past year. This is quite good.
The Revenue has been growing by 15.83% on average over the past years. This is quite good.
EPS 1Y (TTM)64.58%
EPS 3Y20.01%
EPS 5Y7.07%
EPS Q2Q%52.17%
Revenue 1Y (TTM)13.57%
Revenue growth 3Y12.2%
Revenue growth 5Y15.83%
Sales Q2Q%4.58%

3.2 Future

PETQ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.07% yearly.
PETQ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.21% yearly.
EPS Next Y34.03%
EPS Next 2Y25.33%
EPS Next 3Y23.23%
EPS Next 5Y20.07%
Revenue Next Year8.33%
Revenue Next 2Y6.86%
Revenue Next 3Y7.06%
Revenue Next 5Y6.21%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PETQ Yearly Revenue VS EstimatesPETQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
PETQ Yearly EPS VS EstimatesPETQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.61, PETQ is valued on the expensive side.
PETQ's Price/Earnings ratio is a bit cheaper when compared to the industry. PETQ is cheaper than 73.04% of the companies in the same industry.
PETQ is valuated rather cheaply when we compare the Price/Earnings ratio to 26.76, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 16.30, the valuation of PETQ can be described as correct.
73.91% of the companies in the same industry are more expensive than PETQ, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.91, PETQ is valued rather cheaply.
Industry RankSector Rank
PE 19.61
Fwd PE 16.3
PETQ Price Earnings VS Forward Price EarningsPETQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

73.04% of the companies in the same industry are more expensive than PETQ, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PETQ indicates a somewhat cheap valuation: PETQ is cheaper than 60.87% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 77.88
EV/EBITDA 11.52
PETQ Per share dataPETQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of PETQ may justify a higher PE ratio.
PETQ's earnings are expected to grow with 23.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)2.77
EPS Next 2Y25.33%
EPS Next 3Y23.23%

0

5. Dividend

5.1 Amount

No dividends for PETQ!.
Industry RankSector Rank
Dividend Yield N/A

PETIQ INC

NASDAQ:PETQ (10/24/2024, 8:00:01 PM)

After market: 30.98 0 (0%)

30.98

-0.01 (-0.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2024-08-07/bmo
Earnings (Next)11-07 2024-11-07/amc
Inst Owners99.11%
Inst Owner Change-68.73%
Ins Owners0.82%
Ins Owner Change0%
Market Cap933.43M
Analysts76.36
Price Target31.11 (0.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.83%
Min EPS beat(2)33.29%
Max EPS beat(2)38.36%
EPS beat(4)4
Avg EPS beat(4)596.09%
Min EPS beat(4)33.29%
Max EPS beat(4)2252.94%
EPS beat(8)7
Avg EPS beat(8)329.26%
EPS beat(12)9
Avg EPS beat(12)214.99%
EPS beat(16)11
Avg EPS beat(16)161.03%
Revenue beat(2)1
Avg Revenue beat(2)-0.84%
Min Revenue beat(2)-2.32%
Max Revenue beat(2)0.63%
Revenue beat(4)3
Avg Revenue beat(4)7.73%
Min Revenue beat(4)-2.32%
Max Revenue beat(4)18.56%
Revenue beat(8)6
Avg Revenue beat(8)5.08%
Revenue beat(12)9
Avg Revenue beat(12)4.61%
Revenue beat(16)11
Avg Revenue beat(16)4.38%
PT rev (1m)0%
PT rev (3m)5.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.9%
EPS NY rev (1m)0%
EPS NY rev (3m)8.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 19.61
Fwd PE 16.3
P/S 0.82
P/FCF 77.88
P/OCF 46.16
P/B 3.62
P/tB N/A
EV/EBITDA 11.52
EPS(TTM)1.58
EY5.1%
EPS(NY)1.9
Fwd EY6.13%
FCF(TTM)0.4
FCFY1.28%
OCF(TTM)0.67
OCFY2.17%
SpS37.65
BVpS8.56
TBVpS-3.09
PEG (NY)0.58
PEG (5Y)2.77
Profitability
Industry RankSector Rank
ROA 1.48%
ROE 5.13%
ROCE 10.07%
ROIC 7.96%
ROICexc 9.02%
ROICexgc 20.48%
OM 6.32%
PM (TTM) 1.17%
GM 24.63%
FCFM 1.06%
ROA(3y)-2.53%
ROA(5y)-4%
ROE(3y)-9.44%
ROE(5y)-13.98%
ROIC(3y)4.51%
ROIC(5y)N/A
ROICexc(3y)5.32%
ROICexc(5y)N/A
ROICexgc(3y)14.77%
ROICexgc(5y)N/A
ROCE(3y)5.71%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y40.46%
ROICexc growth 3YN/A
ROICexc growth 5Y36.64%
OM growth 3YN/A
OM growth 5Y28.63%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5Y7.79%
F-Score8
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF 36.99
Debt/EBITDA 3.89
Cap/Depr 20.3%
Cap/Sales 0.73%
Interest Coverage 2.16
Cash Conversion 18.01%
Profit Quality 90.51%
Current Ratio 2.58
Quick Ratio 1.68
Altman-Z 2.6
F-Score8
WACC7.57%
ROIC/WACC1.05
Cap/Depr(3y)44.62%
Cap/Depr(5y)115.7%
Cap/Sales(3y)1.83%
Cap/Sales(5y)4.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.58%
EPS 3Y20.01%
EPS 5Y7.07%
EPS Q2Q%52.17%
EPS Next Y34.03%
EPS Next 2Y25.33%
EPS Next 3Y23.23%
EPS Next 5Y20.07%
Revenue 1Y (TTM)13.57%
Revenue growth 3Y12.2%
Revenue growth 5Y15.83%
Sales Q2Q%4.58%
Revenue Next Year8.33%
Revenue Next 2Y6.86%
Revenue Next 3Y7.06%
Revenue Next 5Y6.21%
EBIT growth 1Y62.93%
EBIT growth 3YN/A
EBIT growth 5Y48.99%
EBIT Next Year95.79%
EBIT Next 3Y33.01%
EBIT Next 5Y22.34%
FCF growth 1Y173.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y340.55%
OCF growth 3YN/A
OCF growth 5YN/A